header
Local cover image
Local cover image
Image from OpenLibrary

TCA 35% as a novel therapy for patchy alopecia areata in comparison to intralesional steroid / Tamarah Edries Dhannoon ; Supervised Doaa Mohamed Aly Mahgoub , Marwa Salah Eldin Elmesidy

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Tamarah Edries Dhannoon , 2020Description: 118 P. : charts , facsimiles , photographs ; 25cmOther title:
  • حمض الخليك ثلاثى الكلور ٣٥{u٠٦٦ء} كنوع علاج جديد للثعلبة البقعية مقارنة بحقن الكورتزون الموضعى [Added title page title]
Subject(s): Online resources: Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Dermatology and Venerology Summary: Background: Alopecia Areata (AA) is a common cause of patchy hair loss on the scalp and body. Intralesional corticosteroids (ILCs) is the first-line therapy for patients older than 10 years, however some patients do not respond to glucocorticoid treatment effectively. Also, chemical peels with phenol and lactic acid have been tried successfully in the treatment of alopecia areata. Aim of the work: To evaluate the efficacy of new type of chemical peel (TCA 35%) for the treatment of alopecia areata in comparison to ILCs. Methods: Twenty-two patients with two or more patches of alopecia areata were included in. The mean age of the patients was 25.55 ± 10.62. Two treatment modalities with ILCs and topical TCA 35% were performed in two randomly selected patches. Three sessions were done 3 weeks apart and followed-up for three months. Evaluation was done using Mac Donald Hull and Norris grading system and by counting dermoscopic parameters in each patch. Results: Both ILCs and TCA 35% treated patches showed measurable improvement with no statistically significant difference between the results of the two modalities (p>0.05) at different times of the study. Yellow dots, black dots, exclamation marks and dystrophic hair were all reduced by 100%, 82.0%, 100% and 88.3% in ILCs treated patches and by 70.4%, 69.1%, 100% and 75.0% in TCA treated patches, respectively
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.10.M.Sc.2020.Ta.T (Browse shelf(Opens below)) Not for loan 01010110080735000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.10.M.Sc.2020.Ta.T (Browse shelf(Opens below)) 80735.CD Not for loan 01020110080735000

Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Dermatology and Venerology

Background: Alopecia Areata (AA) is a common cause of patchy hair loss on the scalp and body. Intralesional corticosteroids (ILCs) is the first-line therapy for patients older than 10 years, however some patients do not respond to glucocorticoid treatment effectively. Also, chemical peels with phenol and lactic acid have been tried successfully in the treatment of alopecia areata. Aim of the work: To evaluate the efficacy of new type of chemical peel (TCA 35%) for the treatment of alopecia areata in comparison to ILCs. Methods: Twenty-two patients with two or more patches of alopecia areata were included in. The mean age of the patients was 25.55 ± 10.62. Two treatment modalities with ILCs and topical TCA 35% were performed in two randomly selected patches. Three sessions were done 3 weeks apart and followed-up for three months. Evaluation was done using Mac Donald Hull and Norris grading system and by counting dermoscopic parameters in each patch. Results: Both ILCs and TCA 35% treated patches showed measurable improvement with no statistically significant difference between the results of the two modalities (p>0.05) at different times of the study. Yellow dots, black dots, exclamation marks and dystrophic hair were all reduced by 100%, 82.0%, 100% and 88.3% in ILCs treated patches and by 70.4%, 69.1%, 100% and 75.0% in TCA treated patches, respectively

Issued also as CD

There are no comments on this title.

to post a comment.

Click on an image to view it in the image viewer

Local cover image